Generic Peptides

1 0 0
                                    


Generic Peptides

In addition, CPC specializes in the production of on an industrial scale, following the CGMP's (Current Good Manufacturing Practices). Our expertise allows us to manufacture a range of high-quality generic peptides at a commercial scale. With stringent quality control measures in place, we ensure consistent and reliable production of generic peptides that meet regulatory standards.

Our Portfolio:

 Disease Area

API

Indication

DMF Status

Tumour

Leuprorelin Acetate

Prostate & Breast Cancer;

MFDS: 20200625-210-J-661

Endometriosis; Uterine Leiomyomata;

NMPA: Y20190007496(A)

Precocious Puberty

TFDA: 110DMF050097

Triptorelin Acetate

Prostate & Breast Cancer;

NMPA: Y20170001090(A)

Endometriosis; Uterine Leiomyomata;

Assisted Reproduction

Goserelin Acetate

Suppress production of the sex hormones

NMPA: Y20230000413

Triptorelin Pamoate

Endometriosis; Uterine Fibroids;

NMPA:2024 Q2

Premature Puberty; Prostate Cancer; ART.

Procreation

Cetrorelix Acetate

In Vitro Fertilization (IVF)

NMPA: Y20190001147(A) FDA: 034884

Diabetes

Exenatide Acetate

Exenatide is an injectable diabetes medicine

NMPA: 2015/12

that helps control blood sugar levels.

NMPA: Y20170001378

This medication helps pancreas produce

insulin more efficiently

Semaglutide

Type ll diabetes

DMF: 2024 Q1

NMPA: 2024 Q1

Tirzepatide

Type ll diabetes

Early R&D

Gastrointestinal

Terlipressin Acetate

An analogue of vasopressin, prescribed for

NMPA:Y20200000281(A)

bleeding esophageal varices, septic shock,

CEP : 2020-111

hepatorenal syndrome and in management of

ASMF: The Nethelands (03883)

low blood pressure

ASMF: Germany (4388)

EDQM: R0-CEP 2020-111

Linaclotide

lrritable Bowel Syndrome with Constipation (IBS-C):

NMPA:Y20210000906

Chronic Idiopathic Constipation (CIC)

Teduglutide

A prescription medicine for adults with Short Bowel Syndrome

DMF:2024 Q4

who need additional nutrition or fluids fromIV feeding

Immunology

Difelikefalin

Treatment of moderate-to-severe pruritus associated with

NMPA:2025 Q1

chronic kidney disease(CKD-aP; uremic pruritus)

in adults undergoing hemodialysis

As one of , we will do our best to meet all the needs of customers.

You've reached the end of published parts.

⏰ Last updated: Feb 29 ⏰

Add this story to your Library to get notified about new parts!

Generic PeptidesWhere stories live. Discover now